Insulin glargine, recombinant Subcutaneous and Paraplatin NovaPlus
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Paraplatin NovaPlus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: carboplatin
Brand name: Paraplatin, CARBOplatin Novaplus
Synonyms: Paraplatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Parathyroid hormone
- Insulin glargine, recombinant Subcutaneous-Parathyroid hormone Subcutaneous
- Insulin glargine, recombinant Subcutaneous-Parcopa
- Insulin glargine, recombinant Subcutaneous-Paregoric
- Insulin glargine, recombinant Subcutaneous-Paremyd
- Insulin glargine, recombinant Subcutaneous-Paremyd Ophthalmic
- Paraplatin NovaPlus-Insulin glulisine
- Paraplatin NovaPlus-Insulin Glulisine (Cartridges and Pens)
- Paraplatin NovaPlus-Insulin Glulisine (Vials)
- Paraplatin NovaPlus-Insulin glulisine Subcutaneous
- Paraplatin NovaPlus-Insulin human inhaled Inhalation
- Paraplatin NovaPlus-Insulin human regular Injection